Shopping Cart
Remove All
Your shopping cart is currently empty
Etokimab (ANB-020) is a humanised monoclonal antibody targeting IL-33, capable of inhibiting IL-33-induced neutrophil migration, and is being studied for atopic dermatitis, asthma, and sinusitis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $215 | - | In Stock | |
| 5 mg | $560 | - | In Stock | |
| 10 mg | $896 | - | In Stock |
| Description | Etokimab (ANB-020) is a humanised monoclonal antibody targeting IL-33, capable of inhibiting IL-33-induced neutrophil migration, and is being studied for atopic dermatitis, asthma, and sinusitis. |
| In vivo | Methods: A cell migration assay was conducted using human peripheral blood neutrophils treated with Etokimab at a concentration of 5 μg/mL for 1 hour. Results: Etokimab significantly inhibited neutrophil migration. [1] |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-33 |
| Molecular Weight | 146.54 kDa |
| Cas No. | 2022981-44-6 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.